Board of Directors for review of the economic and financial management data relating to Revenues and main KPIs for the third quarter of 2023 (unaudited)
Categories
Farmacosmo InvestorsFarmacosmo InvestorsBoard of Directors for review of the economic and financial management data relating to Revenues and main KPIs for the third quarter of 2023 (unaudited)